1-5 of 5
Amy McLemore
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Interim Results of the CMML scrna-seq atlas: GMP skewing is independently associated with overall survival in CMML.

Free
Amy McLemore, Surendra Neupane, Zena Komrokji, Maria Balasis, Traci Kruer, Umesh Padia, Sean Murphy, Aline Renneville, Nathalie Droin, Dorothée Selimoglu-Buet, Miguel Martinez, chaomei Zhang, Tania Mesa, Sean Yoder, David Sallman, Andrew Kuykendall, Christopher Ryder, Rami Komrokji, Mrinal Patnaik, Meghan Ferrall-Fairbanks, Regina Barzilay, Eric Solary, Eric Padron
Journal: Blood
Blood (2025) 146 (Supplement 1): 3840.
https://doi.org/10.1182/blood-2025-3840
Published: 2025
Journal Articles

Predictors of outcomes to allogeneic hematopoietic cell transplantation (allo-HCT) for TP53 mutant myelodysplastic neoplasms (MDS) and acute myeloid leukemia (AML) patients and impact of hypomethylating agent (HMA) maintenance therapy

Free
Caroline Wagstaff, Asmita Mishra, Amy McLemore, Onyee Chan, Rory Shallis, Joseph Pidala, Andrew Kuykendall, Samuel Reynolds, Hany Elmariah, Najla Al Ali, Nancy Torres, Zhuoer Xie, Lia Perez, Rawan Faramand, Alison Walker, Taiga Nishihori, Eric Padron, Jeffrey Lancet, Nelli Bejanyan, Rami Komrokji, David Sallman
Journal: Blood
Blood (2025) 146 (Supplement 1): 4291.
https://doi.org/10.1182/blood-2025-4291
Published: 2025
Journal Articles

Interim Results of the CMML intercept study: A prospective observational study to evaluate the role of acute inflammation in CMML disease progression

Free
Zhuoer Xie, Christy James, Niraj Neupane, Ekrem Turk, Julie Braish, Hana Qasim, Angela Consagra, Maria Balasis, Joshua Traina, Zena Komrokji, Christopher Ryder, Amy McLemore, Surendra Neupane, Danielle Rud, Qianxing Mo, Valeria Santini, Swayam Joshi, Kavita Ghia, Andrew Kuykendall, Jeffrey Lancet, Rami Komrokji, Dana Rollison, David Sallman, Mrinal Patnaik, Eric Padron
Journal: Blood
Blood (2025) 146 (Supplement 1): 788.
https://doi.org/10.1182/blood-2025-788
Published: 2025
Journal Articles

XPO1 drives resistance to eprenetapopt and azacitidine and can be targeted in TP53 -mutated myeloid malignancies

Available to Purchase
Traci L. Kruer, Ariel Quintana, Hannah Newman, Meghan Ferrall-Fairbanks, Ling Zhang, Amy McLemore, Surendra Neupane, Qin Yang, Nana Adjoa Ben-Crentsil, Maria E. Balasis, Christopher Letson, Rami Komrokji, Sana Chaudhry, Tulasigeri M. Totiger, Joshua Traina, Maria E. Figueroa, Christopher B. Ryder, Thomas Cluzeau, Justin Taylor, David A. Sallman, Eric Padron
Journal: Blood
Blood (2025) 146 (18): 2244–2258.
https://doi.org/10.1182/blood.2025028803
Published: 2025
Includes: Supplemental data
Journal Articles

Phase 1b/2 Study Evaluating the Safety and Efficacy of Canakinumab with Darbepoetin Alfa in Patients with Lower-Risk Myelodysplastic Syndromes (MDS) Who Have Failed Erythropoietin Stimulating Agents (ESA)

Free
David A Sallman, Anthony M Hunter, Zhuoer Xie, Amy McLemore, Andrew T. Kuykendall, Lisa Ann Nardelli, Onyee Chan, Eric Padron, Jeffrey Lancet, Rami S. Komrokji
Journal: Blood
Blood (2023) 142 (Supplement 1): 4620.
https://doi.org/10.1182/blood-2023-189226
Published: 2023